Welcome to LookChem.com Sign In|Join Free
  • or
5-bromo-3-hydroxyisoindolin-1-one is a chemical compound that belongs to the class of isoindolinones. It is a brominated derivative of 3-hydroxyisoindolin-1-one, characterized by the presence of a bromo group in its structure. This unique feature endows it with distinctive reactivity and selectivity in various chemical transformations, making it a versatile compound with potential applications in both chemical and biological fields.

573675-39-5

Post Buying Request

573675-39-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

573675-39-5 Usage

Uses

Used in Medicinal Chemistry:
5-bromo-3-hydroxyisoindolin-1-one is used as a potential anti-cancer and anti-inflammatory agent due to its biological activities. Its unique structure allows it to modulate various signaling pathways and target specific cellular processes, offering therapeutic benefits in the treatment of cancer and inflammatory diseases.
Used in Organic Synthesis:
5-bromo-3-hydroxyisoindolin-1-one is used as a building block in the synthesis of pharmaceutical compounds. Its reactivity and selectivity in chemical transformations make it a valuable component in the development of new drugs and other bioactive molecules.
Used in Chemical Transformations:
5-bromo-3-hydroxyisoindolin-1-one is used as a versatile reagent in various chemical reactions, such as cross-coupling, substitution, and cyclization. Its unique bromo group allows for selective functionalization and the formation of new chemical bonds, contributing to the synthesis of complex organic molecules.
Used in Drug Development:
5-bromo-3-hydroxyisoindolin-1-one is used as a starting material in the development of new drugs. Its potential as an anti-cancer and anti-inflammatory agent, along with its versatility in chemical transformations, makes it a promising candidate for the design and synthesis of novel therapeutic agents.
Used in Research and Development:
5-bromo-3-hydroxyisoindolin-1-one is used as a research tool in the study of chemical reactivity, selectivity, and the development of new synthetic methods. Its unique properties and potential applications in medicinal chemistry and drug development make it an important compound for further investigation and exploration.

Check Digit Verification of cas no

The CAS Registry Mumber 573675-39-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,3,6,7 and 5 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 573675-39:
(8*5)+(7*7)+(6*3)+(5*6)+(4*7)+(3*5)+(2*3)+(1*9)=195
195 % 10 = 5
So 573675-39-5 is a valid CAS Registry Number.

573675-39-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-3-hydroxy-2,3-dihydroisoindol-1-one

1.2 Other means of identification

Product number -
Other names 5-bromo-3-hydroxy-2,3-dihydro-isoindol-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:573675-39-5 SDS

573675-39-5Relevant academic research and scientific papers

Pesticidal compositions and processes related thereto

-

Page/Page column 92-93, (2016/01/09)

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Page/Page column 91; 92, (2014/07/08)

This document discloses molecules having the following formula ("Formula One"): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 0437-0438, (2014/06/25)

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Page/Page column 92; 93, (2014/07/08)

This document discloses molecules having the following formula ("Formula One") and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Paragraph 0604, (2014/06/25)

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Page/Page column, (2014/06/25)

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

-

Page/Page column 49, (2013/02/28)

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PHTHALAZINE DERIVATIVES

-

Page/Page column 54-55, (2008/12/05)

The present invention relates to novel phthalazine derivatives and, more particularly, to phthalazine derivatives that are useful as protein kinase inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and methods of treatment using the compounds.

PHTHALAZINE, AZA- AND DIAZA-PHTHALAZINE COMPOUNDS AND METHODS OF USE

-

Page/Page column 46-47, (2008/06/13)

The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A1, A2/su

A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties

Dyck, Brian,Markison, Stacy,Zhao, Liren,Tamiya, Junko,Grey, Jonathan,Rowbottom, Martin W.,Zhang, Mingzhu,Vickers, Troy,Sorensen, Katie,Norton, Christi,Wen, Jenny,Heise, Christopher E.,Saunders, John,Conlon, Paul,Madan, Ajay,Schwarz, David,Goodfellow, Val S.

, p. 3753 - 3756 (2007/10/03)

Melanin-concentrating hormone receptor antagonists containing thieno- and a benzopyridazinone cores were designed and tested as potential anorectic agents. These ligands showed high affinity for the receptor, potent functional activity in vitro, and good oral bioavailability in rats. The thiophene analogue exhibited low iv clearance, long half-life, and high brain penetration. In obese rats, the thienopyridazinone demonstrated a dose-dependent reduction in feeding and body weight with doses between 1 and 10 mg kg-1.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 573675-39-5